New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.
Establishing preclinical models of Alzheimer\u2019s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer\u2019s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
International Stammering Awareness Day is 22 October and this year's theme is \"Being Seen, Being Heard \u2013 Representation and normalisation of stuttering in the mainstream.\"
Professor Christopher Fairburn has been awarded the 2022 American Psychological Association (APA) Award for Distinguished Scientific Applications of Psychology.
Health and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability
Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).
Professor Zolt\u00e1n Moln\u00e1r delivers the first Keynote Lecture at the 116th Annual Meeting of the Anatomische Gesellschaft, which this year is held as a Joint Meeting with the Anatomical Society for the first time.
Congratulations are in order for Professor Gero Miesenb\u00f6ck, who is to be awarded the 2022 Louisa Gross Horwitz Prize, together with Professors Karl Deisseroth and Peter Hegemann, for research that laid the foundation for the field of optogenetics.
A new study investigates immune mechanisms that underlie a brain disease called NMDAR-antibody encephalitis, an autoimmune disease in which antibodies are produced, and subsequently disrupt brain NMDA receptors, crucial in maintaining normal brain function.
Congratulations are in order to four members of our Oxford Neuroscience Community who have been awarded the title of Professor in the recent Recognition of Distinction round.
![\"\"](\"https://www.neuroscience.ox.ac.uk/news/the-risk-of-seizures-and-epilepsy-is-higher-after-covid-than-after-the-flu/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n